Vernakalant Selectively Prolongs Atrial Refractoriness With No Effect on Ventricular Refractoriness or Defibrillation Threshold in Pigs-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Vernakalant Selectively Prolongs Atrial Refractoriness With No Effect on Ventricular Refractoriness or Defibrillation Threshold in Pigs

Published:2011-03 Issue:3 Volume:57 Page:302-307
ISSN:0160-2446
Container-title:Journal of Cardiovascular Pharmacology
language:en
Short-container-title:Journal of Cardiovascular Pharmacology

Author:

Bechard Jeff,Gibson John Ken,Killingsworth Cheryl R,Wheeler Jeffery J,Schneidkraut Marlowe J,Huang Jian,Ideker Raymond E,McAfee Donald A

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Pharmacology

Reference19 articles.

1. Vernakalant Hydrochloride for Rapid Conversion of Atrial Fibrillation

2. The Mechanism of Atrial Antiarrhythmic Action of RSD1235

3. Vernakalant (RSD1235): a novel, atrial-selective antifibrillatory agent

4. RSD1235 blocks late INa and suppresses early afterdepolarizations and torsades de pointes induced by class III agents

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti‐arrhythmic investigations in large animal models of atrial fibrillation;British Journal of Pharmacology;2021-04-30

2. Investigational Anti–Atrial Fibrillation Pharmacology and Mechanisms by Which Antiarrhythmics Terminate the Arrhythmia: Where Are We in 2020?;Journal of Cardiovascular Pharmacology;2020-11

3. The KCa2 Channel Inhibitor AP30663 Selectively Increases Atrial Refractoriness, Converts Vernakalant-Resistant Atrial Fibrillation and Prevents Its Reinduction in Conscious Pigs;Frontiers in Pharmacology;2020-02-28

4. Termination of Vernakalant-Resistant Atrial Fibrillation by Inhibition of Small-Conductance Ca 2+ -Activated K + Channels in Pigs;Circulation: Arrhythmia and Electrophysiology;2017-10

5. Normal Values for Heart Electrophysiology Parameters of Healthy Swine Determined on Electrophysiology Study;Advances in Clinical and Experimental Medicine;2016-12-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3